Valacyclovir for Recurrent HSV-1 Labial Episode

Recommended Treatment Regimen

• The CDC recommends episodic therapy for recurrent HSV infections, including valacyclovir 500 mg orally twice daily for 5 days, for patients with recurrent HSV-1 labial episodes 1, 2
• Alternative regimens for patients with recurrent HSV-1 labial episodes, if 500mg formulation is unavailable, include acyclovir 400 mg orally three times daily for 5 days, acyclovir 800 mg orally twice daily for 5 days, acyclovir 200 mg orally five times daily for 5 days, and famciclovir 125 mg orally twice daily for 5 days, as recommended by the CDC 1, 2

Critical Timing Considerations

• Treatment for recurrent HSV-1 labial episodes must be initiated during the prodrome or within 1 day after onset of lesions for maximum benefit, as recommended by the CDC 1, 2
• Patients with recurrent HSV-1 labial episodes should be provided with a prescription or medication supply to enable self-initiation at the first sign of prodrome or lesions in future episodes, as recommended by the CDC 1, 2

Important Clinical Pitfalls

• Topical acyclovir is substantially less effective than oral therapy for recurrent HSV-1 labial episodes and should not be used, according to the CDC and medical guidelines 1, 3
• Daily suppressive therapy should be discussed for patients with recurrent HSV-1 labial episodes who experience ≥6 recurrences per year, as recommended by the CDC 1, 2
• Suppressive regimens for patients with recurrent HSV-1 labial episodes include valacyclovir 500 mg orally once daily, valacyclovir 1g orally once daily, and acyclovir 400 mg orally twice daily, as recommended by the CDC 1, 2
• Suppressive therapy reduces recurrence frequency by ≥75% and is safe for up to 6 years with acyclovir and 1 year with valacyclovir, according to medical guidelines 1, 2

Patient Education Points

• Antiviral medications control symptoms but do not eradicate the virus or prevent all recurrences of HSV-1 labial episodes, as stated by medical guidelines 1
• Asymptomatic viral shedding can occur, potentially leading to transmission of HSV-1 labial episodes, according to medical guidelines 1
• Patients with HSV-1 labial infections typically have less frequent recurrences than those with HSV-2 genital infections, as stated by medical guidelines 3
• Patients with recurrent HSV-1 labial episodes should keep medication on hand for future episodes to enable immediate treatment at prodrome onset, as recommended by the CDC 1, 2